Circadian Rhythm Sleep Disorders

Neurologic Clinics

Volumn 30, Issue 4, 2012, Pages 1167-1191

  Zhu, Lirong ^a   Zee, Phyllis C ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Circadian rhythm; Jet lag; Light; Melatonin; Shift work; Sleep phase

Indexed keywords

ARMODAFINIL; CAFFEINE; HYPNOTIC AGENT; MELATONIN; MODAFINIL; RAMELTEON; ZOLPIDEM;

ADVANCED SLEEP PHASE DISORDER; BEDTIME DOSAGE; CIRCADIAN RHYTHM; CIRCADIAN RHYTHM SLEEP DISORDER; CLINICAL FEATURE; DELAYED SLEEP PHASE DISORDER; FREE RUNNING DISORDER; HUMAN; HYPERNYCHTHEMERAL SYNDROME; HYPOTHALAMUS; IRREGULAR SLEEP WAKE RHYTHM; JET LAG; LIGHT EXPOSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; RISK FACTOR; SHIFT WORK DISORDER; SLEEP DISORDER; SLEEP QUALITY; SLEEP WAKING CYCLE; SOMNOLENCE; SUPRACHIASMATIC NUCLEUS; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME;

ADOLESCENT; CIRCADIAN RHYTHM; HUMANS; MALE; MELATONIN; SLEEP DISORDERS, CIRCADIAN RHYTHM; TREATMENT OUTCOME; WAKEFULNESS;

EID: 84867919507     PISSN: 07338619     EISSN: 15579875     Source Type: Journal    
DOI: 10.1016/j.ncl.2012.08.011     Document Type: Review

References (128)

1. Stephan F.K., Zucker I. Circadian rhythms in drinking behavior and locomotor activity of rats are eliminated by hypothalamic lesions. Proc Natl Acad Sci U S A 1972, 69:1583-1586.
2. Green D.J., Gillette R. Circadian rhythm of firing rate recorded from single cells in the rat suprachiasmatic brain slice. Brain Res 1982, 245:198-200.
3. Groos G., Hendriks J. Circadian rhythms in electrical discharge of rat suprachiasmatic neurones recorded in vitro. Neurosci Lett 1982, 34:283-288.
4. Hofman M.A., Fliers E., Goudsmit E., et al. Morphometric analysis of the suprachiasmatic and paraventricular nuclei in the human brain: sex differences and age-dependent changes. J Anat 1988, 160:127-143.
5. Swaab D.F., Fliers E., Partiman T.S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res 1985, 342:37-44.
6. McNamara P., Seo S.B., Rudic R.D., et al. Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 2001, 105:877-889.
7. Storch K.F., Lipan O., Leykin I., et al. Extensive and divergent circadian gene expression in liver and heart. Nature 2002, 417:78-83.
8. Yamazaki S., Numano R., Abe M., et al. Resetting central and peripheral circadian oscillators in transgenic rats. Science 2000, 288:682-685.
9. Fukuhara C., Tosini G. Peripheral circadian oscillators and their rhythmic regulation. Front Biosci 2003, 8:d642-d651.
10. Young M.E., Bray M.S. Potential role for peripheral circadian clock dyssynchrony in the pathogenesis of cardiovascular dysfunction. Sleep Med 2007, 8:656-667.
11. Klerman E.B. Clinical aspects of human circadian rhythms. J Biol Rhythms 2005, 20:375-386.
12. Czeisler C.A., Duffy J.F., Shanahan T.L., et al. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science 1999, 284:2177-2181.
13. Yagita K., Tamanini F., van Der Horst G.T., et al. Molecular mechanisms of the biological clock in cultured fibroblasts. Science 2001, 292:278-281.
14. Dunlap J.C. Molecular bases for circadian clocks. Cell 1999, 96:271-290.
15. Gekakis N., Staknis D., Nguyen H.B., et al. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280:1564-1569.
16. Preitner N., Damiola F., Lopez-Molina L., et al. The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002, 110:251-260.
17. Eide E.J., Virshup D.M. Casein kinase I: another cog in the circadian clockworks. Chronobiol Int 2001, 18:389-398.
18. Akashi M., Tsuchiya Y., Yoshino T., et al. Control of intracellular dynamics of mammalian period proteins by casein kinase I epsilon (CKIepsilon) and CKIdelta in cultured cells. Mol Cell Biol 2002, 22:1693-1703.
19. Vanselow K., Vanselow J.T., Westermark P.O., et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS). Genes Dev 2006, 20:2660-2672.
20. Ko C.H., Takahashi J.S. Molecular components of the mammalian circadian clock. Hum Mol Genet 2006, 15(Spec No 2):R271-R277.
21. Shearman L.P., Sriram S., Weaver D.R., et al. Interacting molecular loops in the mammalian circadian clock. Science 2000, 288:1013-1019.
22. Guillaumond F., Dardente H., Giguere V., et al. Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 2005, 20:391-403.
23. Toh K.L. Basic science review on circadian rhythm biology and circadian sleep disorders 2008, vol. 37. Annals of the Academy of Medicine, Singapore, p. 662-8.
24. Czeisler C.A., Allan J.S., Strogatz S.H., et al. Bright light resets the human circadian pacemaker independent of the timing of the sleep-wake cycle. Science 1986, 233:667-671.
25. Freedman M.S., Lucas R.J., Soni B., et al. Regulation of mammalian circadian behavior by non-rod, non-cone, ocular photoreceptors. Science 1999, 284:502-504.
26. Ruby N.F., Brennan T.J., Xie X., et al. Role of melanopsin in circadian responses to light. Science 2002, 298:2211-2213.
27. Moore R.Y., Speh J.C., Card J.P. The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells. J Comp Neurol 1995, 352:351-366.
28. Pickard G.E. Bifurcating axons of retinal ganglion cells terminate in the hypothalamic suprachiasmatic nucleus and the intergeniculate leaflet of the thalamus. Neurosci Lett 1985, 55:211-217.
29. Reppert S.M., Perlow M.J., Ungerleider L.G., et al. Effects of damage to the suprachiasmatic area of the anterior hypothalamus on the daily melatonin and cortisol rhythms in the rhesus monkey. J Neurosci 1981, 1:1414-1425.
30. Jin X., von Gall C., Pieschl R.L., et al. Targeted disruption of the mouse Mel(1b) melatonin receptor. Mol Cell Biol 2003, 23:1054-1060.
31. Liu C., Weaver D.R., Jin X., et al. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 1997, 19:91-102.
32. Lewy A.J., Bauer V.K., Ahmed S., et al. The human phase response curve (PRC) to melatonin is about 12 hours out of phase with the PRC to light. Chronobiol Int 1998, 15:71-83.
33. Lewy A.J., Ahmed S., Jackson J.M., et al. Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiol Int 1992, 9:380-392.
34. Buxton O.M., Frank S.A., L'Hermite-Baleriaux M., et al. Roles of intensity and duration of nocturnal exercise in causing phase delays of human circadian rhythms. Am J Physiol 1997, 273:E536-E542.
35. Van Reeth O., Sturis J., Byrne M.M., et al. Nocturnal exercise phase delays circadian rhythms of melatonin and thyrotropin secretion in normal men. Am J Physiol 1994, 266:E964-E974.
36. Dijk D.J., Czeisler C.A. Paradoxical timing of the circadian rhythm of sleep propensity serves to consolidate sleep and wakefulness in humans. Neurosci Lett 1994, 166:63-68.
37. The international classification of sleep disorders: diagnostic and coding manual, ICSD-2 2005, American Academy of Sleep Medicine, Westchester (IL). 2nd edition.
38. Benloucif S., Guico M.J., Reid K.J., et al. Stability of melatonin and temperature as circadian phase markers and their relation to sleep times in humans. J Biol Rhythms 2005, 20:178-188.
39. Schrader H., Bovim G., Sand T. The prevalence of delayed and advanced sleep phase syndromes. J Sleep Res 1993, 2:51-55.
40. Pelayo R.P., Thorpy M.J., Glovinski P. Prevalence of delayed sleep phase syndrome among adolescents. Sleep Res 1988, 17:392.
41. Regestein Q.R., Monk T.H. Delayed sleep phase syndrome: a review of its clinical aspects. Am J Psychiatry 1995, 152:602-608.
42. Weitzman E.D., Czeisler C.A., Coleman R.M., et al. Delayed sleep phase syndrome. A chronobiological disorder with sleep-onset insomnia. Arch Gen Psychiatry 1981, 38:737-746.
43. Archer S.N., Carpen J.D., Gibson M., et al. Polymorphism in the PER3 promoter associates with diurnal preference and delayed sleep phase disorder. Sleep 2010, 33:695-701.
44. Pereira D.S., Tufik S., Louzada F.M., et al. Association of the length polymorphism in the human Per3 gene with the delayed sleep-phase syndrome: does latitude have an influence upon it?. Sleep 2005, 28:29-32.
45. Archer S.N., Robilliard D.L., Skene D.J., et al. A length polymorphism in the circadian clock gene Per3 is linked to delayed sleep phase syndrome and extreme diurnal preference. Sleep 2003, 26:413-415.
46. Katzenberg D., Young T., Finn L., et al. A CLOCK polymorphism associated with human diurnal preference. Sleep 1998, 21:569-576.
47. Carpen J.D., von Schantz M., Smits M., et al. A silent polymorphism in the PER1 gene associates with extreme diurnal preference in humans. J Hum Genet 2006, 51:1122-1125.
48. Carpen J.D., Archer S.N., Skene D.J., et al. A single-nucleotide polymorphism in the 5'-untranslated region of the hPER2 gene is associated with diurnal preference. J Sleep Res 2005, 14:293-297.
49. Takano A., Uchiyama M., Kajimura N., et al. A missense variation in human casein kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders. Neuropsychopharmacology 2004, 29:1901-1909.
50. Hohjoh H., Takasu M., Shishikura K., et al. Significant association of the arylalkylamine N-acetyltransferase (AA-NAT) gene with delayed sleep phase syndrome. Neurogenetics 2003, 4:151-153.
51. Hohjoh H., Takahashi Y., Hatta Y., et al. Possible association of human leucocyte antigen DR1 with delayed sleep phase syndrome. Psychiatry Clin Neurosci 1999, 53:527-529.
52. Ozaki N., Iwata T., Itoh A., et al. Body temperature monitoring in subjects with delayed sleep phase syndrome. Neuropsychobiology 1988, 20:174-177.
53. Uchiyama M., Okawa M., Shibui K., et al. Altered phase relation between sleep timing and core body temperature rhythm in delayed sleep phase syndrome and non-24-hour sleep-wake syndrome in humans. Neurosci Lett 2000, 294:101-104.
54. Watanabe T., Kajimura N., Kato M., et al. Sleep and circadian rhythm disturbances in patients with delayed sleep phase syndrome. Sleep 2003, 26:657-661.
55. Aoki H., Ozeki Y., Yamada N. Hypersensitivity of melatonin suppression in response to light in patients with delayed sleep phase syndrome. Chronobiol Int 2001, 18:263-271.
56. Czeisler C.A., Richardson G.S., Coleman R.M., et al. Chronotherapy: resetting the circadian clocks of patients with delayed sleep phase insomnia. Sleep 1981, 4:1-21.
57. Uchiyama M., Okawa M., Shibui K., et al. Poor recovery sleep after sleep deprivation in delayed sleep phase syndrome. Psychiatry Clin Neurosci 1999, 53:195-197.
58. Uchiyama M., Okawa M., Shibui K., et al. Poor compensatory function for sleep loss as a pathogenic factor in patients with delayed sleep phase syndrome. Sleep 2000, 23:553-558.
59. Morgenthaler T.I., Lee-Chiong T., Alessi C., et al. Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report. Sleep 2007, 30:1445-1459.
60. Schrader H., Bovim G., Sand T. Depression in the delayed sleep phase syndrome. Am J Psychiatry 1996, 153:1238.
61. Shirayama M., Shirayama Y., Iida H., et al. The psychological aspects of patients with delayed sleep phase syndrome (DSPS). Sleep Med 2003, 4:427-433.
62. Rosenthal N.E., Joseph-Vanderpool J.R., Levendosky A.A., et al. Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome. Sleep 1990, 13:354-361.
63. Dahlitz M., Alvarez B., Vignau J., et al. Delayed sleep phase syndrome response to melatonin. Lancet 1991, 337:1121-1124.
64. Mundey K., Benloucif S., Harsanyi K., et al. Phase-dependent treatment of delayed sleep phase syndrome with melatonin. Sleep 2005, 28:1271-1278.
65. Nagtegaal J.E., Kerkhof G.A., Smits M.G., et al. Delayed sleep phase syndrome: a placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset. J Sleep Res 1998, 7:135-143.
66. Oldani A., Ferini-Strambi L., Zucconi M., et al. Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation. Neuroreport 1994, 6:132-134.
67. Nagtegaal J.E., Laurant M.W., Kerkhof G.A., et al. Effects of melatonin on the quality of life in patients with delayed sleep phase syndrome. J Psychosom Res 2000, 48:45-50.
68. Toh K.L., Jones C.R., He Y., et al. An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome. Science 2001, 291:1040-1043.
69. Xu Y., Padiath Q.S., Shapiro R.E., et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature 2005, 434:640-644.
70. Jones C.R., Campbell S.S., Zone S.E., et al. Familial advanced sleep-phase syndrome: a short-period circadian rhythm variant in humans. Nat Med 1999, 5:1062-1065.
71. Rufiange M., Dumont M., Lachapelle P. Correlating retinal function with melatonin secretion in subjects with an early or late circadian phase. Invest Ophthalmol Vis Sci 2002, 43:2491-2499.
72. Lack L., Wright H. The effect of evening bright light in delaying the circadian rhythms and lengthening the sleep of early morning awakening insomniacs. Sleep 1993, 16:436-443.
73. Campbell S.S., Dawson D., Anderson M.W. Alleviation of sleep maintenance insomnia with timed exposure to bright light. J Am Geriatr Soc 1993, 41:829-836.
74. Sack R.L., Lewy A.J., Blood M.L., et al. Circadian rhythm abnormalities in totally blind people: incidence and clinical significance. J Clin Endocrinol Metab 1992, 75:127-134.
75. Hayakawa T., Uchiyama M., Kamei Y., et al. Clinical analyses of sighted patients with non-24-hour sleep-wake syndrome: a study of 57 consecutively diagnosed cases. Sleep 2005, 28:945-952.
76. Uchiyama M., Shibui K., Hayakawa T., et al. Larger phase angle between sleep propensity and melatonin rhythms in sighted humans with non-24-hour sleep-wake syndrome. Sleep 2002, 25:83-88.
77. Reid K.J., Zee P.C. Circadian rhythm disorders. Semin Neurol 2009, 29:393-405.
78. Boivin D.B., James F.O., Santo J.B., et al. Non-24-hour sleep-wake syndrome following a car accident. Neurology 2003, 60:1841-1843.
79. Ayalon L., Borodkin K., Dishon L., et al. Circadian rhythm sleep disorders following mild traumatic brain injury. Neurology 2007, 68:1136-1140.
80. Oren D.A., Wehr T.A. Hypernychthemeral syndrome after chronotherapy for delayed sleep phase syndrome. N Engl J Med 1992, 327:1762.
81. Sack R.L., Brandes R.W., Kendall A.R., et al. Entrainment of free-running circadian rhythms by melatonin in blind people. N Engl J Med 2000, 343:1070-1077.
82. Lewy A.J., Bauer V.K., Hasler B.P., et al. Capturing the circadian rhythms of free-running blind people with 0.5 mg melatonin. Brain Res 2001, 918:96-100.
83. Hack L.M., Lockley S.W., Arendt J., et al. The effects of low-dose 0.5-mg melatonin on the free-running circadian rhythms of blind subjects. J Biol Rhythms 2003, 18:420-429.
84. Kamgar-Parsi B., Wehr T.A., Gillin J.C. Successful treatment of human non-24-hour sleep-wake syndrome. Sleep 1983, 6:257-264.
85. Hoogendijk W.J., van Someren E.J., Mirmiran M., et al. Circadian rhythm-related behavioral disturbances and structural hypothalamic changes in Alzheimer's disease. Int Psychogeriatr 1996, 8(Suppl 3):245-252. [discussion: 269-72].
86. Witting W., Kwa I.H., Eikelenboom P., et al. Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry 1990, 27:563-572.
87. Pollak C.P., Stokes P.E. Circadian rest-activity rhythms in demented and nondemented older community residents and their caregivers. J Am Geriatr Soc 1997, 45:446-452.
88. Palm L., Blennow G., Wetterberg L. Correction of non-24-hour sleep/wake cycle by melatonin in a blind retarded boy. Ann Neurol 1991, 29:336-339.
89. Wagner D.R. Disorders of the circadian sleep-wake cycle. Neurol Clin 1996, 14:651-670.
90. Zee P.C., Vitiello M.V. Circadian rhythm sleep disorder: irregular sleep wake rhythm type. Sleep Med Clin 2009, 4:213-218.
91. Mishima K., Okawa M., Hishikawa Y., et al. Morning bright light therapy for sleep and behavior disorders in elderly patients with dementia. Acta Psychiatr Scand 1994, 89:1-7.
92. Dowling G.A., Burr R.L., Van Someren E.J., et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer's disease. J Am Geriatr Soc 2008, 56:239-246.
93. McCurry S.M., Gibbons L.E., Logsdon R.G., et al. Nighttime insomnia treatment and education for Alzheimer's disease: a randomized, controlled trial. J Am Geriatr Soc 2005, 53:793-802.
94. Martin J.L., Marler M.R., Harker J.O., et al. A multicomponent nonpharmacological intervention improves activity rhythms among nursing home residents with disrupted sleep/wake patterns. J Gerontol A Biol Sci Med Sci 2007, 62:67-72.
95. Riemersma-van der Lek R.F., Swaab D.F., Twisk J., et al. Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA 2008, 299:2642-2655.
96. Gehrman P.R., Connor D.J., Martin J.L., et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am J Geriatr Psychiatry 2009, 17:166-169.
97. Pillar G., Shahar E., Peled N., et al. Melatonin improves sleep-wake patterns in psychomotor retarded children. Pediatr Neurol 2000, 23:225-228.
98. Drake C.L., Roehrs T., Richardson G., et al. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep 2004, 27:1453-1462.
99. Harma M.I., Hakola T., Akerstedt T., et al. Age and adjustment to night work. Occup Environ Med 1994, 51:568-573.
100. Folkard S., Monk T.H., Lobban M.C. Short and long-term adjustment of circadian rhythms in 'permanent' night nurses. Ergonomics 1978, 21:785-799.
101. Knauth P., Landau K., Droge C., et al. Duration of sleep depending on the type of shift work. Int Arch Occup Environ Health 1980, 46:167-177.
102. Akerstedt T. Work hours, sleepiness and the underlying mechanisms. J Sleep Res 1995, 4:15-22.
103. Morgenthaler T., Alessi C., Friedman L., et al. Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. Sleep 2007, 30:519-529.
104. Hart C.L., Ward A.S., Haney M., et al. Zolpidem-related effects on performance and mood during simulated night-shift work. Exp Clin Psychopharmacol 2003, 11:259-268.
105. Moon C.A., Hindmarch I., Holland R.L. The effect of zopiclone 7.5 mg on the sleep, mood and performance of shift workers. Int Clin Psychopharmacol 1990, 5(Suppl 2):79-83.
106. Hart C.L., Haney M., Nasser J., et al. Combined effects of methamphetamine and zolpidem on performance and mood during simulated night shift work. Pharmacol Biochem Behav 2005, 81:559-568.
107. Van Camp R.O. Zolpidem in fatigue management for surge operations of remotely piloted aircraft. Aviat Space Environ Med 2009, 80:553-555.
108. Monchesky T.C., Billings B.J., Phillips R., et al. Zopiclone in insomniac shiftworkers. Evaluation of its hypnotic properties and its effects on mood and work performance. Int Arch Occup Environ Health 1989, 61:255-259.
109. Walsh J.K., Schweitzer P.K., Anch A.M., et al. Sleepiness/alertness on a simulated night shift following sleep at home with triazolam. Sleep 1991, 14:140-146.
110. Dawson D., Campbell S.S. Timed exposure to bright light improves sleep and alertness during simulated night shifts. Sleep 1991, 14:511-516.
111. Crowley S.J., Lee C., Tseng C.Y., et al. Combinations of bright light, scheduled dark, sunglasses, and melatonin to facilitate circadian entrainment to night shift work. J Biol Rhythms 2003, 18:513-523.
112. Boivin D.B., James F.O. Circadian adaptation to night-shift work by judicious light and darkness exposure. J Biol Rhythms 2002, 17:556-567.
113. Eastman C.I., Stewart K.T., Mahoney M.P., et al. Dark goggles and bright light improve circadian rhythm adaptation to night-shift work. Sleep 1994, 17:535-543.
114. Campbell S.S., Dijk D.J., Boulos Z., et al. Light treatment for sleep disorders: consensus report. III. Alerting and activating effects. J Biol Rhythms 1995, 10:129-132.
115. Cajochen C. Alerting effects of light. Sleep Med Rev 2007, 11:453-464.
116. Bjorvatn B., Stangenes K., Oyane N., et al. Randomized placebo-controlled field study of the effects of bright light and melatonin in adaptation to night work. Scand J Work Environ Health 2007, 33:204-214.
117. Czeisler C.A., Walsh J.K., Roth T., et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N Engl J Med 2005, 353:476-486.
118. Muehlbach M.J., Walsh J.K. The effects of caffeine on simulated night-shift work and subsequent daytime sleep. Sleep 1995, 18:22-29.
119. Babkoff H., French J., Whitmore J., et al. Single-dose bright light and/or caffeine effect on nocturnal performance. Aviat Space Environ Med 2002, 73:341-350.
120. Czeisler C.A., Walsh J.K., Wesnes K.A., et al. Armodafinil for treatment of excessive sleepiness associated with shift work disorder: a randomized controlled study. Mayo Clin Proc 2009, 84:958-972.
121. Boulos Z., Campbell S.S., Lewy A.J., et al. Light treatment for sleep disorders: consensus report. VII. Jet lag. J Biol Rhythms 1995, 10:167-176.
122. Burgess H.J., Crowley S.J., Gazda C.J., et al. Preflight adjustment to eastward travel: 3 days of advancing sleep with and without morning bright light. J Biol Rhythms 2003, 18:318-328.
123. Eastman C.I., Gazda C.J., Burgess H.J., et al. Advancing circadian rhythms before eastward flight: a strategy to prevent or reduce jet lag. Sleep 2005, 28:33-44.
124. Beaumont M., Batejat D., Pierard C., et al. Caffeine or melatonin effects on sleep and sleepiness after rapid eastward transmeridian travel. J Appl Physiol 2004, 96:50-58.
125. Srinivasan V., Spence D.W., Pandi-Perumal S.R., et al. Jet lag: therapeutic use of melatonin and possible application of melatonin analogs. Travel Med Infect Dis 2008, 6:17-28.
126. Zee P.C., Wang-Weigand S., Wright K.P., et al. Effects of ramelteon on insomnia symptoms induced by rapid, eastward travel. Sleep Med 2010, 11:525-533.
127. Rosenberg R.P., Bogan R.K., Tiller J.M., et al. A phase 3, double-blind, randomized, placebo-controlled study of armodafinil for excessive sleepiness associated with jet lag disorder. Mayo Clin Proc 2010, 85:630-638.
128. Jamieson A.O., Zammit G.K., Rosenberg R.S., et al. Zolpidem reduces the sleep disturbance of jet lag. Sleep medicine 2001, 2:423-430.